244 related articles for article (PubMed ID: 35969834)
21. Specific gut microbiome members are associated with distinct immune markers in pediatric allogeneic hematopoietic stem cell transplantation.
Ingham AC; Kielsen K; Cilieborg MS; Lund O; Holmes S; Aarestrup FM; Müller KG; Pamp SJ
Microbiome; 2019 Sep; 7(1):131. PubMed ID: 31519210
[TBL] [Abstract][Full Text] [Related]
22. Acute Steroid-Refractory Gastrointestinal Graft-Versus-Host Disease Is Not Associated With Significant Differences in Gut Taxonomic Composition Compared to Steroid-Sensitive Gastrointestinal Graft-Versus-Host Disease Immediately Before Onset of Disease.
Zeng K; Brewster R; Kang JB; Tkachenko E; Brooks E; Bhatt AS; Fodor AA; Andermann TM
Transplant Cell Ther; 2024 Feb; 30(2):237.e1-237.e9. PubMed ID: 37944820
[TBL] [Abstract][Full Text] [Related]
23. The composition of the intestinal microbiota after allogeneic haematopoietic stem cell transplantation and its association with graft versus host disease as assessed by 16Sribosomal ribonucleic acid.
Li DS; Wu YR; Du WH; Zhu YL; Zhang WJ; Fu Y; Yang GB
J Physiol Pharmacol; 2023 Feb; 74(1):. PubMed ID: 37245237
[TBL] [Abstract][Full Text] [Related]
24. Fecal microbiota transfer for refractory intestinal graft-versus-host disease - Experience from two German tertiary centers.
Goeser F; Sifft B; Stein-Thoeringer C; Farowski F; Strassburg CP; Brossart P; Higgins PG; Scheid C; Wolf D; Holderried TAW; Vehreschild MJGT; Cruz Aguilar MR
Eur J Haematol; 2021 Aug; 107(2):229-245. PubMed ID: 33934412
[TBL] [Abstract][Full Text] [Related]
25. Fecal Microbiota Transplantation for Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation: Expanding the Horizon into Pediatrics.
Gray AN; DeFilipp Z
Transplant Cell Ther; 2023 Aug; 29(8):484-491. PubMed ID: 37169290
[TBL] [Abstract][Full Text] [Related]
26. The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease.
Staffas A; Burgos da Silva M; van den Brink MR
Blood; 2017 Feb; 129(8):927-933. PubMed ID: 27940475
[TBL] [Abstract][Full Text] [Related]
27. Gut microbiota intervention by pre and probiotics can induce regulatory T cells and reduce the risk of severe acute GVHD following allogeneic hematopoietic stem cell transplantation.
Yazdandoust E; Hajifathali A; Roshandel E; Zarif MN; Pourfathollah AA; Parkhideh S; Mehdizadeh M; Amini-Kafiabad S
Transpl Immunol; 2023 Jun; 78():101836. PubMed ID: 37037266
[TBL] [Abstract][Full Text] [Related]
28. Severity of acute gastrointestinal graft-vs-host disease is associated with incidence of bloodstream infection after adult allogeneic hematopoietic stem cell transplantation.
Modi A; Rybicki L; Majhail NS; Mossad SB
Transpl Infect Dis; 2020 Feb; 22(1):e13217. PubMed ID: 31769584
[TBL] [Abstract][Full Text] [Related]
29. [Clinical study of 19 cases of steroid-refractory gastrointestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with fecal microbiota transplantation].
Zheng YY; Yang XT; Lin GQ; Bian MR; Si YJ; Zhang XX; Zhang YM; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):401-407. PubMed ID: 37550190
[No Abstract] [Full Text] [Related]
30. A single strain of Bacteroides fragilis protects gut integrity and reduces GVHD.
Sofi MH; Wu Y; Ticer T; Schutt S; Bastian D; Choi HJ; Tian L; Mealer C; Liu C; Westwater C; Armeson KE; Alekseyenko AV; Yu XZ
JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33554953
[TBL] [Abstract][Full Text] [Related]
31. A phase 2 trial of the somatostatin analog pasireotide to prevent GI toxicity and acute GVHD in allogeneic hematopoietic stem cell transplant.
Ramalingam S; Siamakpour-Reihani S; Bohannan L; Ren Y; Sibley A; Sheng J; Ma L; Nixon AB; Lyu J; Parker DC; Bain J; Muehlbauer M; Ilkayeva O; Kraus VB; Huebner JL; Spitzer T; Brown J; Peled JU; van den Brink M; Gomes A; Choi T; Gasparetto C; Horwitz M; Long G; Lopez R; Rizzieri D; Sarantopoulos S; Chao N; Sung AD
PLoS One; 2021; 16(6):e0252995. PubMed ID: 34170918
[TBL] [Abstract][Full Text] [Related]
32. Fecal calprotectin and serum albumin as markers of gastrointestinal graft versus host disease.
Broglie L; Rademaker A; Galvin J; Ray A; Tse WT; Duerst R; Schneiderman J; Kletzel M; Chaudhury S
Hematol Oncol Stem Cell Ther; 2018 Sep; 11(3):169-174. PubMed ID: 29397331
[TBL] [Abstract][Full Text] [Related]
33. A Promising Insight: The Potential Influence and Therapeutic Value of the Gut Microbiota in GI GVHD.
Li J; Zhang X; Chen Y; Zheng Q; Zhao M; Jiang H
Oxid Med Cell Longev; 2022; 2022():2124627. PubMed ID: 35571252
[TBL] [Abstract][Full Text] [Related]
34. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
Shono Y
Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
[TBL] [Abstract][Full Text] [Related]
35. Longitudinal relationship between the gut microbiota variation and diversity and gut graft-versus-host disease (GVHD) following pediatric allogeneic hematopoietic cell transplantation (HCT) - Case series.
Gray AN; Tobin NH; Moore TB; Li F; Aldrovandi GM
Int J Med Microbiol; 2023 May; 313(3):151580. PubMed ID: 37121094
[TBL] [Abstract][Full Text] [Related]
36. [Relationship Between the Change of Microbial Diversity and Gastrointestinal Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation].
Chen XY; Wang SQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):239-245. PubMed ID: 30738477
[TBL] [Abstract][Full Text] [Related]
37. Clostridioides difficile Infection and Risk of Acute Graft-versus-Host Disease among Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
Jabr R; El Atrouni W; Shune L; Telfah M; Gao G; He J; Abhyankar S; McGuirk J; Clough L
Transplant Cell Ther; 2021 Feb; 27(2):176.e1-176.e8. PubMed ID: 33830032
[TBL] [Abstract][Full Text] [Related]
38. The role of microbiota in allogeneic hematopoietic stem cell transplantation.
Chang CC; Hayase E; Jenq RR
Expert Opin Biol Ther; 2021 Aug; 21(8):1121-1131. PubMed ID: 33412949
[TBL] [Abstract][Full Text] [Related]
39. Lactose drives
Stein-Thoeringer CK; Nichols KB; Lazrak A; Docampo MD; Slingerland AE; Slingerland JB; Clurman AG; Armijo G; Gomes ALC; Shono Y; Staffas A; Burgos da Silva M; Devlin SM; Markey KA; Bajic D; Pinedo R; Tsakmaklis A; Littmann ER; Pastore A; Taur Y; Monette S; Arcila ME; Pickard AJ; Maloy M; Wright RJ; Amoretti LA; Fontana E; Pham D; Jamal MA; Weber D; Sung AD; Hashimoto D; Scheid C; Xavier JB; Messina JA; Romero K; Lew M; Bush A; Bohannon L; Hayasaka K; Hasegawa Y; Vehreschild MJGT; Cross JR; Ponce DM; Perales MA; Giralt SA; Jenq RR; Teshima T; Holler E; Chao NJ; Pamer EG; Peled JU; van den Brink MRM
Science; 2019 Nov; 366(6469):1143-1149. PubMed ID: 31780560
[TBL] [Abstract][Full Text] [Related]
40. Severity of Acute Graft-versus-Host Disease and Associated Healthcare Resource Utilization, Cost, and Outcomes.
Farhadfar N; Leather HL; Wang S; Burton N; IrizarryGatell V; Itzler R; Salloum RG; Wingard JR
Transplant Cell Ther; 2021 Dec; 27(12):1007.e1-1007.e8. PubMed ID: 34537422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
